Clinical Trials
0
0 active
Approvals
29
Total approvals
Agencies
1
Regulatory bodies
Founded
N/A
No trial phase data available
No trial data available
No trial data available
- Midwest Poultry Services voluntarily recalled approximately 1.59 million dozen white and brown cage-free shell eggs produced at Texas farms due to potential Salmonella Enteritidis contamination. - The eggs were distributed between June 6 and July 3, 2026, with sell-by dates from July 20 to August 17, 2026, to retail and foodservice customers in Texas, Oklahoma, Louisiana, and nearby states. - Consumers are advised not to eat the recalled eggs and to return them to the place of purchase for a full refund; no confirmed illnesses have been reported to date. - Salmonella can cause serious and sometimes fatal infections, particularly in young children, the elderly, and immunocompromised individuals.
- K.C. Pharmaceuticals voluntarily recalled 3,111,072 bottles of over-the-counter eye drops in early March after the FDA cited a "lack of assurance of sterility." - The recalled products include multiple formulations sold under various brand names at major retailers including CVS, Walgreens, Rite Aid, Kroger, and other pharmacy chains. - The FDA classified this as a Class II recall, indicating the products may cause temporary or medically reversible adverse health consequences. - No injuries have been reported yet associated with the recalled eye drops, though consumers are advised to stop using affected products and contact retailers for refunds.
- A new study reveals that patients taking GLP-1 weight loss medications often develop nutrient deficiencies "pretty much from the start" of treatment, leading to serious health complications. - Researchers found that nutrient deficiencies are causing unexpected conditions including scurvy from vitamin C deficiency, bone loss from inadequate calcium and vitamin D, and gout from high red meat consumption. - Health experts emphasize the critical importance of comprehensive nutrition education alongside GLP-1 treatment, recommending balanced meals with at least three food groups per plate. - While GLP-1 medications show promise for cardiovascular benefits including preventing heart attacks and improving heart failure symptoms, proper dietary management remains essential for patient safety.
